Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 523

1.

[Drug resistance mediated by ABC transporters].

Yoshikawa M, Ito A, Ishikawa T, Ikegami Y.

Gan To Kagaku Ryoho. 2004 Jan;31(1):1-6. Review. Japanese.

PMID:
14750312
2.

Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.

Leslie EM, Deeley RG, Cole SP.

Toxicol Appl Pharmacol. 2005 May 1;204(3):216-37. Review.

PMID:
15845415
3.

Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.

To KKW, Wu X, Yin C, Chai S, Yao S, Kadioglu O, Efferth T, Ye Y, Lin G.

J Ethnopharmacol. 2017 May 5;203:110-119. doi: 10.1016/j.jep.2017.03.051. Epub 2017 Mar 28.

PMID:
28363522
4.
6.

Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.

Lepper ER, Nooter K, Verweij J, Acharya MR, Figg WD, Sparreboom A.

Pharmacogenomics. 2005 Mar;6(2):115-38. Review.

PMID:
15882131
7.

Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.

Andersen V, Svenningsen K, Knudsen LA, Hansen AK, Holmskov U, Stensballe A, Vogel U.

World J Gastroenterol. 2015 Nov 7;21(41):11862-76. doi: 10.3748/wjg.v21.i41.11862.

8.

β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.

Teng YN, Sheu MJ, Hsieh YW, Wang RY, Chiang YC, Hung CC.

Phytomedicine. 2016 Mar 15;23(3):316-23. doi: 10.1016/j.phymed.2016.01.008. Epub 2016 Feb 6.

PMID:
26969385
9.
10.

Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.

Pérez-Tomás R.

Curr Med Chem. 2006;13(16):1859-76. Review.

PMID:
16842198
11.
12.

ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS.

Daood M, Tsai C, Ahdab-Barmada M, Watchko JF.

Neuropediatrics. 2008 Aug;39(4):211-8. doi: 10.1055/s-0028-1103272. Epub 2009 Jan 22.

13.

Interactions between ABC-transport proteins and the secondary Fusarium metabolites enniatin and beauvericin.

Dornetshuber R, Heffeter P, Sulyok M, Schumacher R, Chiba P, Kopp S, Koellensperger G, Micksche M, Lemmens-Gruber R, Berger W.

Mol Nutr Food Res. 2009 Jul;53(7):904-20. doi: 10.1002/mnfr.200800384.

PMID:
19517454
14.
15.

Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.

Stein U, Lage H, Jordan A, Walther W, Bates SE, Litman T, Hohenberger P, Dietel M.

Int J Cancer. 2002 Feb 20;97(6):751-60.

16.

9-Deazapurines as Broad-Spectrum Inhibitors of the ABC Transport Proteins P-Glycoprotein, Multidrug Resistance-Associated Protein 1, and Breast Cancer Resistance Protein.

Stefan K, Schmitt SM, Wiese M.

J Med Chem. 2017 Nov 9;60(21):8758-8780. doi: 10.1021/acs.jmedchem.7b00788. Epub 2017 Oct 26.

PMID:
29016119
17.

Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

Ni Z, Bikadi Z, Rosenberg MF, Mao Q.

Curr Drug Metab. 2010 Sep;11(7):603-17. Review.

18.

Human ABCB1 (P-glycoprotein) and ABCG2 mediate resistance to BI 2536, a potent and selective inhibitor of Polo-like kinase 1.

Wu CP, Hsiao SH, Sim HM, Luo SY, Tuo WC, Cheng HW, Li YQ, Huang YH, Ambudkar SV.

Biochem Pharmacol. 2013 Oct 1;86(7):904-13. doi: 10.1016/j.bcp.2013.08.004. Epub 2013 Aug 17.

19.
20.

ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.

Cotte S, von Ahsen N, Kruse N, Huber B, Winkelmann A, Zettl UK, Starck M, König N, Tellez N, Dörr J, Paul F, Zipp F, Lühder F, Koepsell H, Pannek H, Montalban X, Gold R, Chan A.

Brain. 2009 Sep;132(Pt 9):2517-30. doi: 10.1093/brain/awp164. Epub 2009 Jul 15.

PMID:
19605531

Supplemental Content

Support Center